Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-19 1:8:42 pm | Ocular Therapeutics' Impressive Surge: A Strategic Insight | SeekingAlpha |
| 2024-03-13 3:38:32 am | Q4 2023 Clearside Biomedical Inc Earnings Call | Thomson Reuters StreetEvents |
| 2024-03-12 6:55:8 am | Wall Street Analysts Think Ocular Therapeutix (OCUL) Could Surge 34.74%: Read This Before Placing a Bet | Zacks |
| 2024-03-11 2:32:0 pm | Ocular Therapeutix Inc Reports Growth Amidst Strategic Shifts | GuruFocus.com |
| 2024-03-11 2:25:2 pm | Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates | Zacks |
| 2024-03-11 1:26:40 pm | Ocular Therapeutix: Q4 Earnings Snapshot | Associated Press Finance |
| 2024-03-11 1:5:0 pm | Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2023 Results | GlobeNewswire |
| 2024-03-05 4:30:0 am | Ocular Therapeutix™ to Release Fourth Quarter and Full Year 2023 Results on March 11, 2024 | GlobeNewswire |
| 2024-03-01 3:30:0 pm | Criteo, Ocular Therapeutix, and More Stocks See Action From Activist Investors | Barrons.com |
Please consider a small donation if you think this website provides you with relevant information